2244614-14-8
中文名稱
BTRX-335140
英文名稱
4-Piperidinamine, 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-
CAS
2244614-14-8
分子式
C25H32FN5O2
分子量
453.55
MOL 文件
2244614-14-8.mol
更新日期
2024/11/07 22:36:57
2244614-14-8 結(jié)構(gòu)式
基本信息
中文別名
化合物BTRX-3351401-(6-乙基-8-氟-4-甲基-3-(3-甲基-1,2,4-惡二唑-5-基)喹啉-2-基)-N-(四氫-2H-吡喃-4-基)哌啶-4-胺
1-[6-乙基-8-氟-4-甲基-3-(3-甲基-1,2,4-噁二唑-5-基)-2-喹啉基]-N-(四氫-2H-吡喃-4-基)哌啶-4-胺
英文別名
CYM-53093Navacaprant
BTRX-335140
1-[6-Ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolyl]-N-(tetrahydro-2H-pyran-4-yl)piperidin-4-amine
1-(6-Ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)piperidin-4-amine
4-Piperidinamine, 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-
CNS,BTRX-335140,CYM53093,U69593,Inhibitor,U2OS,Opioid Receptor,inhibit,BTRX335140,neurobehavioral disorder,CYM 53093,oral,BTRX 335140